Genetic screens for key transcriptional regulators of antiviral T cell immunity
抗病毒 T 细胞免疫关键转录调节因子的基因筛选
基本信息
- 批准号:8810644
- 负责人:
- 金额:$ 212.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntibody ResponseAntiviral AgentsB-LymphocytesBiologyCD4 Positive T LymphocytesCD8B1 geneCell physiologyCellsCellular biologyChromatinCytotoxic T-LymphocytesDermalEffector CellEquilibriumFutureGene ExpressionGenerationsGenesGenetic ScreeningGenetic TranscriptionGoalsHealthHumanHumoral ImmunitiesImmune responseImmunityImmunologyInfectionInterventionKnockout MiceKnowledgeLinkLymphocyteLymphocyte BiologyMalignant NeoplasmsMedicalMemoryMetabolicMusNucleosomesNutrientOxygenPathway interactionsPerceptionPopulationProcessProviderRegulationResearchRoleStagingSystemT cell differentiationT cell responseT memory cellT-Cell ActivationT-LymphocyteTestingTimeTissuesVaccine DesignVaccinesVirus Diseasesadaptive immunitybasecost effectivecytotoxicin vivopathogenprogramsreceptortranscription factorvaccine developmentvaccinologyvector
项目摘要
DESCRIPTION (provided by applicant): Our projects propose a highly integrated approach to revealing the biology of regulation and differentiation of Tfh CD4 T cells, Th1 CD4 T cells, CTL CD8 T cells, and memory CD8 T cells, making use of high throughput genetic screens of T cell response in mice to multiple viral infections. T cell differentiation into various effector cells,and the capacity to differentiate into memory cells, are important parts of adaptive immunity to pathogens and cancers. Transcription factors are central regulators of these differentiation processes. The identification of key transcription factors (TFs) regulating different pathways of CD4 and CD8 T cell differentiation have been central to understanding the biology of these cells. However, it is abundantly clear that TFs do not act in isolation and many TFs may be important inducers or repressors of a T cell differentiation pathway. The biggest challenge to studying TF network biology is that experimental manipulation of more than 1 factor at a time under controlled conditions has not been generally feasible, particularly in primary cells in vivo.
Therefore, the focus on 1 gene at a time has been an experimental necessity for decades, and the large majority of analyses of TF networks have been correlative or computational. The generation of double and triple knockout mice is excessively time consuming. Furthermore, the compelling FANTOM study highlights the importance of moderate changes in TF expression for most cellular differentiation processes, not complete on-off switches. That has always been a clear limitation of knockout mice, and it continues to bias our perception of lymphocyte differentiation and function. Current experimental approaches are insufficient to dramatically advance our understanding of CD4 and CD8 T cell differentiation and function, and lymphocyte biology in general, due to conceptual, time, and monetary limitations. Therefore, our approach to this serious problem has been focused on generating an experimental approach whereby we can modulate and test 100 genes in parallel for their roles in antiviral T cell responses in vivo, using a new shRNAmir vector based approach. We have established this system, and are now able to perform genetic screens, in vivo, in primary CD4 or CDS T cells, probing differentiation and function. The three Projects vigorously pursue an understanding of antiviral CD4 and CD8 T cells, linked by the theme: what transcription factors regulate these cells and how do they do so?
描述(由申请人提供):我们的项目提出了一种高度集成的方法来揭示Tfh CD4 T细胞、Th1 CD4 T细胞、CTL CD8 T细胞和记忆CD8 T细胞的调节和分化的生物学,利用小鼠对多种病毒感染的T细胞应答的高通量遗传筛选。T细胞分化为各种效应细胞,以及分化为记忆细胞的能力,是对病原体和癌症的适应性免疫的重要部分。转录因子是这些分化过程的中心调节因子。鉴定调节CD4和CD8 T细胞分化的不同途径的关键转录因子(TF)对于理解这些细胞的生物学至关重要。然而,非常清楚的是,TF不单独起作用,许多TF可能是T细胞分化途径的重要诱导剂或阻遏物。研究TF网络生物学的最大挑战是在受控条件下一次操作超过1个因子的实验通常不可行,特别是在体内的原代细胞中。
因此,几十年来,一次关注一个基因一直是实验的必要性,并且TF网络的大部分分析都是相关的或计算的。双和三敲除小鼠的产生非常耗时。此外,引人注目的FANTOM研究强调了TF表达的适度变化对大多数细胞分化过程的重要性,而不是完全的开关。这一直是基因敲除小鼠的一个明显局限性,它继续使我们对淋巴细胞分化和功能的看法产生偏见。由于概念、时间和资金的限制,目前的实验方法不足以显著提高我们对CD4和CD8 T细胞分化和功能以及淋巴细胞生物学的理解。因此,我们解决这个严重问题的方法一直专注于产生一种实验方法,通过这种方法,我们可以使用一种新的基于shRNAmir载体的方法,平行调节和测试100个基因在体内抗病毒T细胞应答中的作用。我们已经建立了这个系统,现在能够在体内进行遗传筛选,在原代CD4或CDS T细胞中,探测分化和功能。这三个项目积极追求对抗病毒CD4和CD8 T细胞的理解,主题是:什么转录因子调节这些细胞以及它们是如何做到这一点的?
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shane P Crotty其他文献
Shane P Crotty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shane P Crotty', 18)}}的其他基金
Immune engineering of optimized sequential immunization strategies for HIV vaccines
HIV疫苗序贯免疫策略优化的免疫工程
- 批准号:
10588202 - 财政年份:2021
- 资助金额:
$ 212.71万 - 项目类别:
Immune engineering of optimized sequential immunization strategies for HIV vaccines
HIV疫苗序贯免疫策略优化的免疫工程
- 批准号:
10383728 - 财政年份:2021
- 资助金额:
$ 212.71万 - 项目类别:
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis
人复发性扁桃体炎中滤泡辅助性 T (Tfh) CD4 T 细胞、生发中心和抗体反应功能障碍
- 批准号:
10304742 - 财政年份:2020
- 资助金额:
$ 212.71万 - 项目类别:
Bcl6 and transcription factors that program TFH differentiation and function
Bcl6 和转录因子编程 TFH 分化和功能
- 批准号:
10224892 - 财政年份:2020
- 资助金额:
$ 212.71万 - 项目类别:
Bcl6 and transcription factors that program TFH differentiation and function
Bcl6 和转录因子编程 TFH 分化和功能
- 批准号:
10683269 - 财政年份:2020
- 资助金额:
$ 212.71万 - 项目类别:
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
CD4 和 CD8 T 细胞效应及记忆分化和功能的转录因子调节
- 批准号:
10024583 - 财政年份:2020
- 资助金额:
$ 212.71万 - 项目类别:
相似海外基金
Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
描述 SARS-CoV-2 抗体反应及其与患者因素的关联:参与 GENCOV 研究的参与者的血清学分析
- 批准号:
495256 - 财政年份:2023
- 资助金额:
$ 212.71万 - 项目类别:
Understanding the human antibody response to a malaria transmission-blocking vaccine
了解人类抗体对疟疾传播阻断疫苗的反应
- 批准号:
MR/X009491/1 - 财政年份:2023
- 资助金额:
$ 212.71万 - 项目类别:
Research Grant
Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
- 批准号:
10549646 - 财政年份:2023
- 资助金额:
$ 212.71万 - 项目类别:
Identification of the antigenic targets of the clonal antibody response to Clostridioides difficile infection
鉴定针对艰难梭菌感染的克隆抗体反应的抗原靶点
- 批准号:
10742376 - 财政年份:2023
- 资助金额:
$ 212.71万 - 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
- 批准号:
10688292 - 财政年份:2022
- 资助金额:
$ 212.71万 - 项目类别:
Molecular dissection of IgA antibody response by developing monoclonal IgA antibodies from nasal mucosa of mice
通过从小鼠鼻粘膜中开发单克隆 IgA 抗体对 IgA 抗体反应进行分子剖析
- 批准号:
22H02875 - 财政年份:2022
- 资助金额:
$ 212.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
- 批准号:
10634694 - 财政年份:2022
- 资助金额:
$ 212.71万 - 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
- 批准号:
10514498 - 财政年份:2022
- 资助金额:
$ 212.71万 - 项目类别:
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
- 批准号:
10527979 - 财政年份:2022
- 资助金额:
$ 212.71万 - 项目类别:
Factors related to antibody response of COVID-19 vaccines: with focusing on metabolomics
与 COVID-19 疫苗抗体反应相关的因素:重点关注代谢组学
- 批准号:
22H03334 - 财政年份:2022
- 资助金额:
$ 212.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)